IR-Med (IRME) Stock Price & Analysis

IRME Stock Chart & Stats

$0.04$0.00(0.00%)

At close: Oct 30 4:00 PM EDT

Day’s Range: $0.04 - $0.04
52-Week Range: $0.02 - $0.05
Previous Close: $0.04
Volume: N/A
Average Volume (3M): 0
Market Cap: $204.49K
Enterprise Value: $727.67B
Total Cash (Recent Filing): $63.00K
Total Debt (Recent Filing): $250.00K
Price to Earnings (P/E): ―
Beta: -0.72
Next Earnings: N/A
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

IR-Med News

IR-MED and Dice Technologies Announce collaboration to Evaluate and Advance Pressure-Injury Prevention Platform in Japan

Rosh Pinna, Israel, September 16th, 2026, FinanceWire Letter of Intent (“LOI”) signed to cooperate in the evaluation, research support, localization, commercialization preparation and regulatory preparation of the PressureSafe™ medical device

1M agoIRME

IR-Med Names Co-Founder Yaniv Cohen Interim CEO

An announcement from IR-Med ( ($IRME) ) is now available. On September 14, 2026, IR-Med, Inc. appointed company co-founder Yaniv Cohen as interim Chief Executive Officer, reflecting a leadership transition

1M ago8K IRME

IR-Med Completes Insider-Backed Private Placement Financing

An update from IR-Med ( ($IRME) ) is now available. On May 31, 2026, IR-Med, Inc. completed a private placement of 250,000 common shares at $0.10 each, together with warrants

5M ago8K IRME

IR-Med Announces Insider-Backed Private Placement Amid CEO Exit

The latest update is out from IR-Med ( ($IRME) ). On February 4, 2026, IR-Med, Inc. entered into a securities purchase agreement with several investors for a private placement of

9M ago8K IRME

IR-Med Amends Executive Compensation Amid Financial Struggles

An announcement from IR-Med ( ($IRME) ) is now available. On December 7, 2025, IR-Med, Inc. amended the employment agreements of its CEO, Ran Ziskind, and CFO, Sharon Levkoviz, transitioning

10M ago8K IRME

IR-Med Completes Private Placement Offering

The latest update is out from IR-Med ( ($IRME) ). On September 16, 2025, IR-Med, Inc. completed a private placement offering, issuing 1,562,500 shares of common stock and warrants to

1y ago8K IRME

IR-Med Converts Debt into Equity Shares

IR-Med ( ($IRME) ) just unveiled an update. On September 5, 2025, IR-Med, Inc. converted its outstanding debt obligations into shares of its capital stock, effectively terminating prior loan agreements.

1y ago8K IRME

IR-Med Completes Private Placement Offering

IR-Med ( ($IRME) ) has provided an update. On August 28, 2025, IR-Med, Inc. entered into a Securities Purchase Agreement with investors to issue and sell shares of its common

1y ago8K IRME

IR-Med Announces Termination of Chief Development Officer

IR-Med ( ($IRME) ) just unveiled an announcement. On August 3, 2025, IR-Med, Inc. announced the termination of Aharon Binur as Chief Development Officer, effective August 31, 2025. The company

1y ago8K IRME

IR-Med Announces CFO Employment Agreement Amendment

The latest update is out from IR-Med ( ($IRME) ). On July 23, 2025, IR-Med, Inc. announced a second amendment to the employment agreement with its Chief Financial Officer, Mr.

1y ago8K IRME

IRME FAQ

What was IR-Med’s price range in the past 12 months?

IR-Med lowest stock price was $0.02 and its highest was $0.05 in the past 12 months.

What is IR-Med’s market cap?

IR-Med’s market cap is $204.49K.

When is IR-Med’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

Is IR-Med overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does IR-Med pay dividends?

IR-Med does not currently pay dividends.

What is IR-Med’s EPS estimate?

IR-Med’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does IR-Med have?

IR-Med has 97,377,690 shares outstanding.

Which hedge fund is a major shareholder of IR-Med?

Currently, no hedge funds are holding shares in IRME

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

IR-Med

IR-Med Inc. is an emerging medical technology firm dedicated to developing advanced diagnostic and medical solutions by leveraging a platform that integrates infra-red light spectroscopy with artificial intelligence. The company's product pipeline includes PressureSafe, a handheld optical monitoring device engineered for the early identification of pressure-induced tissue damage in the skin and subcutaneous layers, often resulting from extended periods of patient immobility. Additionally, IR-Med is developing Nobiotics, an innovative otoscope designed to provide medical professionals with immediate feedback on the presence of middle ear infections (Otitis Media), a prevalent condition among pediatric patients. IR-Med Inc. operates from its headquarters in Rosh Pina, Israel.

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	7	3	7
Technical Analysis	3	1	3
Moving Averages	4	2	4

Technical Analysis >

Similar Stocks

Stocks similar to IRME
Company	Price & Change	Follow
NUWENuwellis
AEMDAethlon Medical

Compare IRME Stocks >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft

IRME Stock Chart & Stats

IR-Med News

IR-MED and Dice Technologies Announce collaboration to Evaluate and Advance Pressure-Injury Prevention Platform in Japan

IR-Med Names Co-Founder Yaniv Cohen Interim CEO

IR-Med Completes Insider-Backed Private Placement Financing

IR-Med Announces Insider-Backed Private Placement Amid CEO Exit

IR-Med Amends Executive Compensation Amid Financial Struggles

IR-Med Completes Private Placement Offering

IR-Med Converts Debt into Equity Shares

IR-Med Completes Private Placement Offering

IR-Med Announces Termination of Chief Development Officer

IR-Med Announces CFO Employment Agreement Amendment

IRME FAQ

Company Description

IR-Med

Technical Analysis

Overall Consensus

Similar Stocks

Popular Stocks

Become an Expert with TipRanks Premium